Christina Greenaway
Overview
Explore the profile of Christina Greenaway including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1666
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fontaine G, Taylor N, Bruneau J, Kronfli N, Greenaway C, Biondi M, et al.
Lancet Gastroenterol Hepatol
. 2025 Mar;
PMID: 40054488
No abstract available.
2.
Sahakyan Y, Erman A, Wong W, Greenaway C, Janjua N, Kwong J, et al.
Viruses
. 2024 Aug;
16(8).
PMID: 39205198
Background: The World Health Organization (WHO) has set hepatitis C (HCV) elimination targets for 2030. Understanding existing gaps in the "HCV care-cascade" is essential for meeting these targets. We aimed...
3.
Olawoye I, Waglechner N, McIntosh F, Akochy P, Cloutier N, Grandjean Lapierre S, et al.
J Infect Dis
. 2024 Aug;
231(2):e396-e406.
PMID: 39189818
Background: Mycobacterium abscessus complex (MABC), an opportunistic nontuberculous mycobacteria, can lead to poor clinical outcomes in pulmonary infections. Conflicting data exist on person-to-person transmission of MABC within and across health...
4.
Passos-Castilho A, Murphy D, Blouin K, Benedetti A, Panagiotoglou D, Bruneau J, et al.
Viruses
. 2024 Mar;
16(3).
PMID: 38543755
To achieve hepatitis C virus (HCV) elimination, high uptake along the care cascade steps for all will be necessary. We mapped engagement with the care cascade overall and among priority...
5.
Greenwald Z, Werb D, Feld J, Austin P, Fridman D, Bayoumi A, et al.
J Clin Epidemiol
. 2024 Mar;
170:111332.
PMID: 38522754
Objectives: Health administrative data can be used to improve the health of people who inject drugs by informing public health surveillance and program planning, monitoring, and evaluation. However, methodological gaps...
6.
Forouzannia F, Hamadeh A, Passos-Castilho A, Erman A, Yu A, Feng Z, et al.
Liver Int
. 2024 Mar;
44(6):1383-1395.
PMID: 38445848
Background: Patients with chronic hepatitis C (CHC) can be cured with the new highly effective interferon-free combination treatments (DAA) that were approved in 2014. However, CHC is a largely silent...
7.
Erman A, Sahakyan Y, Everett K, Greenaway C, Janjua N, Kwong J, et al.
Can J Gastroenterol Hepatol
. 2024 Mar;
2024:5573068.
PMID: 38434933
Background: Data on the economic burden of chronic hepatitis C (CHC) among immigrants are limited. Our objective was to estimate the CHC-attributable mortality and healthcare costs among immigrants in Ontario,...
8.
Dagher O, Passos-Castilho A, Sareen V, Labbe A, Barkati S, Luong M, et al.
J Immigr Minor Health
. 2023 Oct;
26(1):3-14.
PMID: 37902902
Language barriers (LB) contribute to coronavirus disease 2019 (COVID-19) health inequities. People with LB were more likely to be SARS-CoV-2 positive despite lower testing and had higher rates of hospitalization....
9.
Erman A, Everett K, Wong W, Forouzannia F, Greenaway C, Janjua N, et al.
Hepatol Commun
. 2023 Aug;
7(9).
PMID: 37556245
Background: HCV elimination requires a thorough understanding of the care cascade. A direct-acting antiviral (DAA)-era description of the care cascade has not been undertaken in Ontario, Canada's most populous jurisdiction....
10.
Barkati S, Greenaway C, Libman M
Curr Opin Infect Dis
. 2023 Apr;
36(3):203-208.
PMID: 37093059
Purpose Of Review: Strongyloidiasis is a soil-transmitted helminthiasis, a neglected tropical disease that affects 300-900 million individuals globally. Strongyloides stercoralis is associated with cutaneous, respiratory, and gastrointestinal clinical manifestations. Chronicity...